EnviroTech :: Biotech
DSM Buys Biotech Firm
12:04 PM MDT | June 12, 2009
DSM says it has agreed to acquire privately held biotechnology company Biopract (Berlin). Financial details of the deal were not disclosed. The acquisition of Biopract will serve as an entry point for DSM into the biogas market, which is growing at 15%-20%/year, DSM says. Biopract focuses mainly on the commercialization and extension of its enzyme series for the improvement of agricultural and industrial biogas...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee